Viewing Study NCT00531960


Ignite Creation Date: 2025-12-25 @ 2:10 AM
Ignite Modification Date: 2026-04-10 @ 9:32 AM
Study NCT ID: NCT00531960
Status: COMPLETED
Last Update Posted: 2014-11-11
First Post: 2007-09-18
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Tarceva (Erlotinib) in Combination With Avastin (Bevacizumab) in Patients With Advanced Non-Small Cell Lung Cancer.
Sponsor: Hoffmann-La Roche
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-01
Start Date Type: None
Primary Completion Date: 2010-01
Primary Completion Date Type: ACTUAL
Completion Date: 2010-01
Completion Date Type: ACTUAL
First Submit Date: 2007-09-18
First Submit QC Date: None
Study First Post Date: 2007-09-19
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2014-11-04
Results First Submit QC Date: None
Results First Post Date: 2014-11-11
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-11-04
Last Update Post Date: 2014-11-11
Last Update Post Date Type: ESTIMATED